How do general practitioners diagnose and refer potential rheumatic musculoskeletal complaints? A scoping review

Review (2026)
Author(s)

Georgy Gomon (Leiden University Medical Center)

Teresa Otón (Instituto de Salud Musculoesquelética)

Loreto Carmona (Instituto de Salud Musculoesquelética)

Saskia le Cessie (Leiden University Medical Center)

Rachel Knevel (Leiden University Medical Center, Newcastle University Translational and Clinical Research Institute, TU Delft - Electrical Engineering, Mathematics and Computer Science)

Research Group
Pattern Recognition and Bioinformatics
DOI related publication
https://doi.org/10.1007/s10067-026-08282-w Final published version
More Info
expand_more
Publication Year
2026
Language
English
Research Group
Pattern Recognition and Bioinformatics
Journal title
Clinical Rheumatology
Issue number
9
Volume number
45
Pages (from-to)
5179-5200
Page Views
11
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Timely diagnosis and referral of rheumatic and musculoskeletal diseases (RMDs) remain challenging in primary care, with substantial diagnostic delays and a high proportion of rheumatology referrals involving patients without inflammatory rheumatic disease. To examine the diagnostic trajectory of patients presenting with RMD-related complaints, we conducted a scoping review. We defined the diagnostic trajectory as the sequence of diagnostic considerations, investigations, management decisions, and referrals from first presentation to diagnosis or specialist referral. Across 47 included studies, early presentations were heterogeneous and non-specific, often leading to repeated consultations and diagnostic revisions. The underlying condition was frequently not suspected initially, requiring multiple visits before it was considered. General practitioners demonstrated reasonable knowledge of inflammatory features, but documentation of these features in routine electronic health records was often incomplete. Laboratory and imaging investigations were widely used and strongly influenced decision-making, functioning as objective gatekeeping tools for referral despite limited diagnostic yield. Marked variation was found between countries in referral patterns and investigations used, suggesting an important role for healthcare system structure in shaping diagnostic trajectories. The evidence base was constrained by predominantly narrow disease-specific populations and few studies capturing the full diagnostic pathway from primary care presentation to specialist diagnosis.Overall, our findings indicate that delayed diagnosis of RMDs reflects knowledge gaps, the ambiguity of early disease, and reliance on objective investigations. Efforts to improve clinical decision-making for early diagnosis and timely referral require consideration of the non-specific, early-stage nature of RMDs in primary care, longitudinal clinical information, and differences between healthcare systems.